crispr stock 5 year forecast

123 million compared to 02 million in the same quarter from a year prior. 15 Wall Street analysts have issued 1-year price targets for CRISPR Therapeutics stock.

Business And Financial News Cnn Money

The average CRISPR Therapeutics AG stock forecast from last 6 month is 1250 and this show a -1672 decrease in average from the prior price target of the each prediction.

. The CRISPR Therapeutics stock prediction results are shown below and presented as a graph table and text information. CRISPR Therapeutics AG has risen higher in 3 of those 5 years over the subsequent 52 week period corresponding to a historical accuracy of 60. Also this average forecast of 1250 represents a -2138 decrease from the past average forecast of 1590 6 months ago from 5.

CRISPR Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. During the day the stock fluctuated 504 from a day low at 6681 to a day high of 7018. CRISPR Stock Forecast Analysis.

Crispr stock 5 year forecast Saturday March 19 2022 Edit For CRISPR Therapeutics AG stock forecast for 2027 5 year 12 predictions are offered for each month of 2027 with average CRISPR Therapeutics AG stock forecast of 16042 a high. Their forecasts range from 6400 to 22000. Ad Wall Street Analysts Forecast For CRSP Stock.

Its official - this tiny company is ready to dominate for the next 10 years. Over the next 52 weeks CRISPR Therapeutics AG has on average historically risen by 497 based on the past 5 years of stock performance. On average they anticipate CRISPR Therapeutics stock price to reach 12983 in the next twelve months.

Genome editing has passed from science fiction to science factWhile the technology is very much still in its infancy a growing number of companies are researching ways to modify DNA sequences in order to treat a variety of genetic conditions and illnesses. CRISPR Therapeutics AG Stock Forecast CRSP stock price prediction. According to our technical indicators the current sentiment is Bearish while the Fear Greed Index is showing NeutralCRSP stock recorded 1130 37 green days with 687 price volatility over the last 30 days.

The minimum target price for CRISPR Therapeutics analysts is 13476. CRISPR Therapeutics AG Stock Forecast. The median estimate represents a 12044 increase from the last price of 6623.

15 brokers have issued 1 year price targets for CRISPR Therapeutics stock. Today 200 Day Moving Average is the. Compare Analysts Price Targets.

According to our current CRSP stock forecast the value of CRISPR Therapeutics AG shares will drop by -124 and reach 6383 per share by April 17 2022. CRISPR reported fourth-quarter earnings on February 15 2022 here are the highlights. Ad When you sign up youll reveal the names and ticker symbols of these 5 companies.

Based on our forecasts a long-term increase is expected the CRSP stock price prognosis for 2027-01-01 is 231335 USDWith a 5-year investment the revenue is expected to be around 24191. 71 rows Close price at the end of the last trading day Monday 4th Apr 2022 of the CRSP stock was 6952. The global CRISPR gene editing market was valued at 8462 million in 2019 and is expected to reach 108251 million by 2030 registering a CAGR of 2686 during the forecast.

Price target in 14 days. CRISPR THERAPEUTICS AG s earnings in 2022 is 377661000On average 13 Wall Street analysts forecast CRSPs earnings for 2022 to be -592649744 with the lowest CRSP earnings forecast at -752179649 and the highest CRSP earnings forecast at -233514789. According to 30 analysts the average rating for CRSP stock is Buy The 12-month stock price forecast is 13746 which is.

CRISPR Therapeutics AG stock forecast by Wall Street Analysts. The best long-term short-term CRISPR Therapeutics AG share. TipRanks Smart Score For CRSP Stock Wall Street Analysts Price Targets Forecasts.

2379 billion compared to 1690 billion from the same period a year prior. This is 5 more than the trading day before Friday 1st Apr 2022. Ad Develop Your Financial Strategy.

The 20 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 14600 with a high estimate of 22000 and a low estimate of 6400. Learn About Long Term Investments. According to Wall Streets consensus estimates these four stocks are forecast to increase sales by 25750 to as much as 2970000 thats nearly 3.

The 20 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 14850 with a high estimate. What will Crispr stock be worth in 5 years. This suggests a possible upside of 1011 from the stocks current price.

Find Out What Services a Dedicated Financial Advisor Offers.

Nb9qcw4zbjm25m

Thriving Biotech Three Stocks Building Momentum

Crispr Technology Market Share Size 2023 Marketsandmarkets

Crsp Crispr Therapeutics Ag Cnnmoney Com

Why Crispr Therapeutics Stock Sank 12 5 In November Nasdaq

Are Institutions Heavily Invested In Crispr Therapeutics Ag S Nasdaq Crsp Shares Nasdaq

Crispr Therapeutics Nasdaq Crsp Shareholders Are Still Up 280 Over 5 Years Despite Pulling Back 5 0 In The Past Week Nasdaq

Global Crispr Market Competition Landscape 2021 2028 Featuring Profiles Of Integrated Dna Technologies Intellia Therapeutics Horizon Discovery Group And Precision Biosciences Among Others Jnews